Weight-Loss Drug Boom Sends Novo Nordisk Profits Soaring. Why the Success Brings Challenges.Barrons • 01/31/24
Novo Nordisk's sales increased by 31% in Danish kroner and by 36% at constant exchange rates to DKK 232.3 billion in 2023GlobeNewsWire • 01/31/24
Is a Surprise Coming for Novo Nordisk (NVO) This Earnings Season?Zacks Investment Research • 01/30/24
Leader In Weight Loss Drugs Nears Buy Point With Earnings Due This WeekInvestors Business Daily • 01/29/24
Novo Nordisk (NVO) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks Investment Research • 01/18/24
Ozempic has transformed Novo Nordisk, but who is next with a me-too weight loss drug?Proactive Investors • 01/15/24
Have Novo Nordisk shares got further to go? This investment bank has its sayProactive Investors • 01/15/24
After Surging 53% in 2023, This Pharmaceutical Stock Might Be About to Crash. Here's Why I'm Probably WrongThe Motley Fool • 01/13/24